Physician profile
Robert Johnston Lingle
NPI 1992931133
$10,173.83
in general payments reported to CMS, 2019-2025
45 companies · $1,577 in 2025
The $1,577 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,579 · 2020: $1,110 · 2021: $1,045 · 2022: $1,639 · 2023: $1,618 · 2024: $1,606 · 2025: $1,577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,801.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,164.61 | 2020-2025 | Aveir, Assurity, Ensite Precision |
| Boston Scientific Corporation | $1,089.13 | 2019-2025 | Watchman Flx, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $690.18 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $636.94 | 2021-2025 | Verquvo, Steglatro, Steglujan |
| Heartflow, INC. | $578.71 | 2019-2025 | |
| Bard Peripheral Vascular, INC. | $525.01 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $485.78 | 2019-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $424.57 | 2019-2023 | Xarelto |
| Amarin Pharma, INC. | $374.45 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $355.45 | 2021-2023 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $267.39 | 2020-2024 | Lifevest |
| Cvrx, INC. | $264.92 | 2021-2024 | Barostim Neo System |
| Kestra Medical Technology Services, INC. | $249.39 | 2024-2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $232.82 | 2019-2025 | Farxiga, Wainua |
| Pfizer INC. | $232.48 | 2019-2024 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lingle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.